Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc (AMPH) Wheel Strategy
AMPH wheel strategy scan found 2 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 24.1%.
Read more
Running a AMPH wheel strategy lets you generate consistent premium income on Amphastar Pharmaceuticals Inc while setting your own entry and exit prices on the underlying. Amphastar Pharmaceuticals Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own AMPH, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best AMPH wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on AMPH, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable AMPH wheel from a losing one.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency.
The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the AMPH wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your AMPH wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Mar 19, 2027 | 20.00 | $0.75 | $2.43 | -0.26 | 184 | 21% | 61.2% | 24.1% | 3 |
| Dec 18, 2026 | 17.50 | $0.15 | $0.43 | -0.11 | 93 | 21% | 83.4% | 9.5% | 62 |
As of September 17, 2026
Run the Wheel on AMPH With Confidence
Find the best AMPH wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→